U.K. researchers announced Thursday that the immune suppressant baricitinib reduced the risk of dying among hospitalized COVID-19 patients by 13%.
Rheumatoid arthritis drug could be lifesaver for severely ill COVID-19 patients
Rheumatoid arthritis drug could be lifesaver…
Rheumatoid arthritis drug could be lifesaver for severely ill COVID-19 patients
U.K. researchers announced Thursday that the immune suppressant baricitinib reduced the risk of dying among hospitalized COVID-19 patients by 13%.